4.8 Article

Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model

期刊

NATURE COMMUNICATIONS
卷 7, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms13275

关键词

-

资金

  1. German Federal Ministry of Research and Education (BMBF
  2. Competence Network Multiple Sclerosis)
  3. European Research Council under the European Union's Seventh Framework Program (FP
  4. ERC) [310932, 616791]
  5. Verein Therapieforschung fur MS-Kranke e.V.
  6. Center for Integrated Protein Science Munich (CIPSM) [EXC 114]
  7. German-Israeli Foundation
  8. Munich Center for Systems Neurology (SyNergy) [EXC 1010]
  9. DFG Priority Program 1710
  10. DFG Collaborative Research Centre [Transregio 128]
  11. Hertie-Foundation (Myelin Repair Foundation)
  12. DFG (Collaborative Research Center 870)
  13. Swiss National Science Foundation [PP00P3_152928]
  14. Klaus-Tschira Foundation
  15. Gebert-Ruf Foundation
  16. Swiss MS Society
  17. Swiss National Science Foundation (SNF) [PP00P3_152928] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Oligodendrocyte damage is a central event in the pathogenesis of the common neuro-inflammatory condition, multiple sclerosis (MS). Where and how oligodendrocyte damage is initiated in MS is not completely understood. Here, we use a combination of light and electron microscopy techniques to provide a dynamic and highly resolved view of oligodendrocyte damage in neuroinflammatory lesions. We show that both in MS and in its animal model structural damage is initiated at the myelin sheaths and only later spreads to the oligodendrocyte cell body. Early myelin damage itself is characterized by the formation of local myelin out-foldings-'myelinosomes'-, which are surrounded by phagocyte processes and promoted in their formation by anti-myelin antibodies and complement. The presence of myelinosomes in actively demyelinating MS lesions suggests that oligodendrocyte damage follows a similar pattern in the human disease, where targeting demyelination by therapeutic interventions remains a major open challenge.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据